Molecular Diagnostic Solutions for Respiratory Testing

Enabling clinical laboratories to identify a variety of pathogens responsible for respiratory tract infections

The TaqPath respiratory portfolio supports respiratory testing with a comprehensive, flexible menu of CE-marked assays. Our CE-marked tests are designed to provide accurate, reliable results with excellent sensitivity and specificity across a wide variety of bacteria and viruses, and help to give confidence in screening, diagnostic, and treatment decisions.

To request pricing information for the TaqPath Respiratory Portfolio, please complete the form and a Thermo Fisher Scientific representative will be in touch.

  • - Select -
  • Antarctica
  • Argentina
  • Bahamas
  • Barbados
  • Belize
  • Bermuda
  • Bolivia
  • Brasil
  • Chile
  • Colombia
  • Costa Rica
  • Curaçao
  • Dominica
  • Dominican Republic
  • Ecuador
  • El Salvador
  • French Guyana
  • Grenada
  • Guadeloupe
  • Guatemala
  • Guyana
  • Haiti
  • Honduras
  • Jamaica
  • Martinique
  • Montserrat
  • México
  • Nicaragua
  • Panamá
  • Paraguay
  • Perú
  • Puerto Rico
  • Suriname
  • Trinidad and Tobago
  • Uruguay
  • Venezuela
  • Virgin Islands (U.S.)
Please select all applicable TaqPath assays to receive a quote

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

For In Vitro Diagnostic Use.
 

Intended use and regulatory statements of products vary. For specific intended use and regulatory statements please refer to the Instructions for Use (IFU). Product availability by country varies. For product availability in your country, check the associated product webpages.
 

These products are manufactured by GeneProof™ for resale by Thermo Fisher Scientific
 

© 2023 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries,  GeneProof™ is the property of GeneProof.